Loading...

PE/Cyanine7 anti-mouse CD11c Antibody

Pricing & Availability
Clone
N418 (See other available formats)
Regulatory Status
RUO
Other Names
αX integrin, integrin αX chain, CR4, p150, ITGAX
Isotype
Armenian Hamster IgG
Ave. Rating
Submit a Review
Product Citations
publications
N418_A_PEslashCy7_Pos_071006
C57BL/6 mouse splenocytes stained with APC anti-mouse I-A/I-E (clone M5/114.15.2) and PE/Cyanine7 N418 (top) or PE/Cyanine7 Armenian hamster IgG isotype control (bottom)
  • N418_A_PEslashCy7_Pos_071006
    C57BL/6 mouse splenocytes stained with APC anti-mouse I-A/I-E (clone M5/114.15.2) and PE/Cyanine7 N418 (top) or PE/Cyanine7 Armenian hamster IgG isotype control (bottom)
  • N418_B_PEslashCy7_Neg_071006
Compare all formats See PE/Cyanine7 spectral data
Cat # Size Price Quantity Check Availability Save
117317 25 µg 94 CHF
Check Availability


Need larger quantities of this item?
Request Bulk Quote
117318 100 µg 231 CHF
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD11c is a 150 kD glycoprotein also known as αX integrin, CR4, and p150. CD11c forms a αXβ2 heterodimer with β2 integrin (CD18). It is primarily expressed on dendritic cells, NK cells, a subset of intestinal intraepithelial lymphocytes (IEL), and some activated T cells. The αXβ2 integrin plays an important role in cell-cell contact by binding its ligands: iC3b, fibrinogen, and CD54.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Armenian Hamster
Immunogen
Mouse spleen dendritic cells
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with PE/Cyanine7 under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is = 0.25 µg per 106 cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for other applications.

Excitation Laser
Blue Laser (488 nm)
Green Laser (532 nm)/Yellow-Green Laser (561 nm)
Application Notes

Additional reported applications (for the relevant formats) include: immunoprecipitation3, immunohistochemical staining of acetone-fixed frozen sections3, immunofluorescence microscopy5, 9 (Alexa Fluor® 488 conjugated N418 was used for IHC in frozen sections10), and spatial biology (IBEX)22,23.

Additional Product Notes

View more applications data for this product in our Scientific Poster Library.

 


BioLegend is in the process of converting the name PE/Cy7 to PE/Cyanine7. The dye molecule remains the same, so you should expect the same quality and performance from our PE/Cyanine7 products. Please contact Technical Service if you have any questions.

 

Application References

(PubMed link indicates BioLegend citation)
  1. Granucci F, et al. 1997. J. Immunol. 159:1794.
  2. Stokes RW, et al. 1998. J. Immunol. 160:5514.
  3. Metlay JP, et al. 1990. J. Exp. Med. 171:1753. (IHC, IP)
  4. Ma XT, et al. 2006. Cancer Research 66:1169.
  5. Chin RK, et al. 2006. J. Immunol. 177:290. (IF)
  6. Cervantes-Barragan L, et al. 2007. Blood 109:1131. (FC) PubMed
  7. Turnquist HR, et al. 2007. J. Immunol. 178:7018. (FC) PubMed
  8. Benson MJ, et al. 2007. J. Exp. Med. doi:10.1084/jem.20070719. (FC) PubMed
  9. You Y, et al. 2009. J. Immunol. 182:7343. (IF) PubMed
  10. Roland CL, et al. 2009. Mol. Cancer Res. 8:1761. (IHC, FC) PubMed
  11. Wikstrom M, et al.2006. J. Immunol. 177:913. PubMed
  12. Pericolini E, et al. 2008. J. Leukocyte Biol. 83:1286. PubMed
  13. Randall LM, et al. 2008. Infect. Immun.76:3312. PubMed
  14. Fahlen-Yrild L, et al. 2009. J. Immunol. 183:5032. PubMed
  15. Osterholzer JJ, et al. 2009. J. Immunol. 183:8044. PubMed
  16. Bankoti J, et al. 2010. Toxicol. Sci. 115:422. (FC) PubMed
  17. Eisenach PA, et al. 2010. J Cell Sci. 123:4182. PubMed
  18. Leppin K, et al. 2014. Invest. Ophthalmol. Vis. Sci. 55:3603. PubMed
  19. Sakai F, et al. 2014. PLoS One. 9:105370. PubMed
  20. Gibbins JD, et al. 2014. Blood. 124:2953. PubMed
  21. White CE, et al. 2015. J Immunol. 194:697. PubMed
  22. Lu X, et al. 2015. J Immunol. 194:2011. PubMed
  23. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  24. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Liu Y, et al. 2021. Cell Metabolism. 33(6):1221-1233.e11. PubMed
  2. Sun L, et al. 2021. Cancer Cell. :. PubMed
  3. Komuczki J, et al. 2019. Immunity. 50:1289. PubMed
  4. Wang X, et al. 2019. Cell Res. 29:787. PubMed
  5. Kimura S, et al. 2020. Nat Commun. 0.620833333. PubMed
  6. Al–Rashed F, et al. 2020. Sci Rep. 10:16802. PubMed
  7. Jiang Z, et al. 2021. J Clin Invest. 131: . PubMed
  8. Zhou R, et al. 2022. EBioMedicine. 75:103762. PubMed
  9. Friess MC, et al. 2022. Cell Rep. 38:110334. PubMed
  10. Hutter K, et al. 2022. Front Immunol. 13:967914. PubMed
  11. Furrer R, et al. 2021. Sci Adv. 7:eabi4852. PubMed
  12. Wiesner DL, et al. 2020. Cell Host Microbe. 614:27. PubMed
  13. Furuta Y, et al. 2017. PLoS One. 12(2):e0172509. PubMed
  14. Kolawole A, et al. 2015. J Virol. 90: 1499-1506. PubMed
  15. Kawano H, et al. 2016. Int Immunol. 28: 489 - 501. PubMed
  16. Shin J, et al. 2016. Sci Rep. 6:23426. PubMed
  17. Fu R, et al. 2020. Sci Rep. 10:1455. PubMed
  18. Fachi JL et al. 2019. Cell reports. 27(3):750-761 . PubMed
  19. Hastings AK, et al. 2019. iScience. 13:339. PubMed
  20. Lyons J, et al. 2018. PLoS Biol. 16:e2002417. PubMed
  21. van Vloten JP, et al. 2022. J Immunother Cancer. 10:. PubMed
  22. Ferrere G, et al. 2021. JCI Insight. 6:. PubMed
  23. Jong RM, et al. 2022. J Immunol. 208:407. PubMed
  24. Ercoli G, et al. 2021. Front Immunol. 11:611661. PubMed
  25. Suzuki T, et al. 2014. J Dermatol Sci. 74:116. PubMed
  26. Clark K, et al. 2015. J Autoimmun. Available online 21 August 2015. PubMed
  27. Ndoja A, et al. 2020. Cell. 182(5):1156-1169.e12. PubMed
  28. Dong L, et al. 2021. Cancer Cell. . PubMed
  29. Yu K, et al. 2021. Cell Reports. 35(12):109273. PubMed
  30. Clarke F,et al. 2017. PLoS One. 10.1371/journal.pone.0186625. PubMed
  31. Thwe PM et al. 2017. Cell metabolism. 26(3):558-567 . PubMed
  32. Kurelac I, et al. 2019. Nat Commun. 10:903. PubMed
  33. Quatrini L, et al. 2018. Nat Immunol. 19:954. PubMed
  34. Shen Y, et al. 2021. Comput Struct Biotechnol J. 19:5360. PubMed
  35. Chen L, et al. 2022. Mol Ther Oncolytics. 24:522. PubMed
  36. Boldison J, et al. 2020. Cell Mol Immunol. 17:843. PubMed
  37. Liang S, et al. 2022. Acta Pharm Sin B. 12:2494. PubMed
  38. Pack AD, et al. 2021. Cell Reports. 36(8):109586. PubMed
  39. Hearnden R, et al. 2021. STAR Protocols. 2(2):100422. PubMed
  40. Yousif AS, et al. 2020. Immunity. 54(2):235-246.e5. PubMed
  41. Ku M, et al. 2016. Mol Cancer Ther. 15: 1975 - 1987. PubMed
  42. Wong E, et al. 2019. Cell Rep. 29:3047. PubMed
  43. Yuzhu Hou et al. 2018. Immunity. 49(3):490-503 . PubMed
  44. Castellanos CA, et al. 2021. Sci Immunol. 6:eabh0707. PubMed
  45. Rao E, et al. 2021. Sci Immunol. 6:. PubMed
  46. Tilstam PV, et al. 2021. J Clin Invest. 131:. PubMed
  47. Yu X, et al. 2021. Nature. 594:560. PubMed
  48. Morgado P, et al. 2014. Infect Immun . 82:4047. PubMed
  49. Ohtsuki T, et al. 2016. J Virol. 90: 300 - 307. PubMed
  50. Bazett M, Haston M 2016. Sci Rep. 6:19189. PubMed
  51. Rao S, et al. 2017. Cell. 168(3):503-516.e12. PubMed
  52. Si Y, et al. 2020. Sci Adv. 6:eaba0995. PubMed
  53. Evren E, et al. 2020. Immunity. 54(2):259-275.e7. PubMed
  54. Schiller M, et al. 2021. Immunity. 54(5):1022-1036.e8. PubMed
  55. Jtte BB, et al. 2021. iScience. 24(8):102833. PubMed
  56. Bartleson JM, et al. 2020. Nat Immunol. 1384:21. PubMed
  57. Dave K et al. 2017. eLife. 6 pii: e23382. PubMed
  58. Go DM, et al. 2021. Cell Mol Gastroenterol Hepatol. 12:715. PubMed
  59. Papafragkos I, et al. 2022. Front Immunol. 13:889075. PubMed
  60. Moreau GB, et al. 2020. Am J Trop Med Hyg. 103:1215. PubMed
  61. van Dierendonck XAMH, et al. 2020. Cell Reports. 30(6):1811-1822. PubMed
  62. Nguyen CM, et al. 2019. Diabetes. 68:1499. PubMed
  63. Britton GJ et al. 2019. Immunity. 50(1):212-224 . PubMed
  64. Lyons J, et al. 2018. Sci Signal. 11. PubMed
  65. Khan IM, et al. 2021. Immunohorizons. 5:703. PubMed
  66. Zhang J, et al. 2022. Front Immunol. 13:931740. PubMed
  67. Zhang C, et al. 2021. Clin Transl Immunology. 10:e1310. PubMed
  68. Francian A, et al. 2021. J Drug Target. 29:754. PubMed
  69. Sato Y, et al. 2021. J Clin Invest. Online ahead of print. PubMed
  70. Bagayoko S, et al. 2021. PLoS Pathog. 17:e1009927. PubMed
  71. Cousin N, et al. 2021. Cancer Res. 81:4133. PubMed
  72. Škrnjug I, et al. 2014. PLoS One. 9:110150. PubMed
  73. Lee M, et al. 2014. PLoS One. 9:112666. PubMed
  74. Syed A, et al. 2015. Infect Immun . 83: 3428-3437. PubMed
  75. Zhang Y, et al. 2015. PLoS Pathog. 11: e1005167. PubMed
  76. Ben-Shaanan T, et al. 2016. Nat Med. 10.1038/nm.4133. PubMed
  77. Koren N, et al. 2021. Cell Host Microbe. 29(2):197-209.e5. PubMed
  78. An J,et al. 2017. Sci Rep.. 10.1038/s41598-017-13629-0. PubMed
  79. Emgård J, et al. 2018. Immunity. 143:419. PubMed
  80. Koliaraki V et al. 2019. Cell reports. 26(3):536-545 . PubMed
  81. Perry JSA, et al. 2018. Immunity. 48:923. PubMed
  82. Zeng J, et al. 2019. Cell Rep. 27:549. PubMed
  83. Davidson S, et al. 2020. Cell Reports. 31(7):107628. PubMed
  84. Wu X, et al. 2021. Elife. 10:. PubMed
  85. Crosse EI, et al. 2020. Cell Stem Cell. 27:822. PubMed
  86. Sellau J, et al. 2016. Sci Rep. 6:28058. PubMed
  87. Rosen D, et al. 2016. J Infect Dis. 213: 649 - 658. PubMed
  88. Kelsey E Sivick et al. 2018. Cell reports. 25(11):3074-3085 . PubMed
  89. Fatkhullina AR et al. 2018. Immunity. 49(5):943-957 . PubMed
  90. Novkovic M, et al. 2016. PLoS Biol. 14: 1002515. PubMed
  91. He Y, et al. 2021. Cell Metabolism. 33(5):988-1000.e7. PubMed
  92. Souza COS, et al. 2021. iScience. 24(6):102548. PubMed
  93. Connick K, et al. 2020. J Parasit Dis. 186:44. PubMed
  94. Johnson LA, et al. 2021. Life Sci Alliance. :4. PubMed
  95. Deng M, et al. 2020. Nat Commun. 11:2193. PubMed
  96. Si Y, et al. 2018. J Control Release. 282:120. PubMed
  97. Baudoux T, et al. 2018. Sci Rep. 4.0375. PubMed
  98. Russler-Germain EV, et al. 2021. Elife. 10:. PubMed
  99. Pan Y, et al. 2022. J Clin Invest. 132:. PubMed
  100. Harb H, et al. 2021. Immunity. 54(6):1186-1199.e7. PubMed
  101. Tacconi C, et al. 2021. Cell Reports. 35(2):108993. PubMed
  102. Dieterich LC, et al. 2020. Angiogenesis. 1.24375. PubMed
  103. Vettorazzi S, et al. 2015. Nat Commun. 6: 7796. PubMed
  104. Christ A, et al. 2018. Cell. 172:162. PubMed
  105. Calcinotto A, et al. 2018. Nat Commun. 9:4832. PubMed
  106. Habib S, et al. 2018. Infect Immun. 86:e00019. PubMed
  107. Krollmann C, et al. 2022. STAR Protoc. 3:101309. PubMed
  108. Harnett MM, et al. 2022. Front Immunol. 13:953053. PubMed
  109. , et al. 2021. Eur J Immunol. 51:2708. PubMed
  110. Ercoli G, et al. 2022. Clin Transl Immunology. 11:e1366. PubMed
  111. Lewis EL, et al. 2021. Front Immunol. 12:741518. PubMed
  112. Panea C, et al. 2021. Commun Biol. 4:913. PubMed
  113. Gibbins J, et al. 2014. Blood. 124:2953. PubMed
  114. Schaefer K, et al. 2014. PLoS One. 9:114824. PubMed
  115. Engler AE, et al. 2020. Cell Reports. 33(13):108553. PubMed
  116. Kim SH, et al. 2021. Cell Reports. 35(2):108995. PubMed
  117. Moon HG et al. 2018. Immunity. 49(2):275-287 . PubMed
  118. Hiebert P et al. 2018. Developmental cell. 46(2):145-161 . PubMed
  119. Tran NT, et al. 2020. STAR Protocols. 1(1):100028. PubMed
  120. Liu S, et al. 2020. Cell Host & Microbe. 26(6):779-794.e8.. PubMed
  121. Liang J, et al. 2020. Sci Adv. 6:eabc3646. PubMed
  122. Nikolos F, et al. 2022. Nat Commun. 13:1487. PubMed
  123. Colombo M, et al. 2022. iScience. 25:105042. PubMed
  124. Reimer E, et al. 2020. J Cell Sci. 134:00:00. PubMed
  125. Cuenca M, et al. 2016. J Immunol. 196: 726 - 737. PubMed
  126. Hayashi K, et al. 2015. Int Immunol. 27: 435-445. PubMed
  127. Ermert D, et al. 2016. PLoS Pathog. 11: 1005043. PubMed
  128. Choi EW, et al. 2020. Sci Rep. 10:12001. PubMed
  129. Yang C, et al. 2019. Nanomedicine (Lond). 14:2423. PubMed
  130. Janela B, et al. 2019. Immunity. 50:1069. PubMed
  131. Puigdelloses M, et al. 2021. J Immunother Cancer. 9:. PubMed
  132. Daneshmandi S, et al. 2021. Elife. 10:. PubMed
  133. Henrich IC, et al. 2021. Cancer Res. 81:2171. PubMed
  134. Monaghan KL, et al. 2020. J Vis Exp. . PubMed
  135. Colliou N, et al. 2015. Toxins. 7: 3805 - 3817. PubMed
  136. Shepardson K, et al. 2016. MBio. 7: e00506-16. PubMed
  137. Wei Z, et al. 2021. Nat Commun. 0.805555556. PubMed
  138. Lan H, et al. 2020. Int Immunol. 559:32. PubMed
  139. Taddio MF, et al. 2021. Mol Imaging Biol. 23:196. PubMed
  140. Zhang X, et al. 2021. Mol Cancer Res. 19:1076. PubMed
  141. Yang X, et al. 2022. Front Immunol. 13:856230. PubMed
  142. Hirata SI, et al. 2020. Allergy. 75:1939. PubMed
  143. Morikawa M, et al. 2016. PLoS One. 11:e0163607. PubMed
  144. Kim M, et al. 2018. Immunity. 49:151. PubMed
  145. Lu Y, et al. 2020. Immunity. 52:782. PubMed
  146. Dahlgren MW et al. 2019. Immunity. 50(3):707-722 . PubMed
  147. Xueyang Yu et al. 2017. Immunity. 47(5):903-912 . PubMed
  148. Nagatake T, et al. 2018. J Allergy Clin Immunol. 142:470. PubMed
  149. Zwick M, et al. 2019. Front Immunol. 10:222. PubMed
  150. Chan WY, et al. 2019. Infect Immun. 87:. PubMed
  151. Ghorbani S, et al. 2022. Nat Commun. 13:2445. PubMed
  152. Clement CC, et al. 2021. Immunity. 54:721. PubMed
  153. Hennion-Tscheltzoff O, et al. 2013. Blood. 121:4684. PubMed
  154. Škrnjug I, et al. 2014. PLoS One. 9:95728. PubMed
  155. Velázquez F, et al. 2016. J Immunol. 196: 1305 - 1316. PubMed
  156. Ghosh D, et al. 2016. J Immunol. 197: 1788 - 1800. PubMed
  157. Yasuda T, et al. 2016. PLoS One. 11:e0167952. PubMed
  158. Kumari P, et al. 2021. Cell Reports. 35(3):109012. PubMed
  159. Liu P, et al. 2020. Mol Cell. 748:77. PubMed
  160. Andersen TK, et al. 2019. NPJ Vaccines. 4:9. PubMed
  161. Lai SM et al. 2018. Cell reports. 25(11):3099-3109 . PubMed
  162. Urata S, et al. 2018. PLoS Pathog. 14:e1007172. PubMed
  163. Zhao Y, et al. 2020. Immunity. 51(6):1059-1073.e9.. PubMed
  164. Li E, et al. 2021. Front Immunol. 12:667177. PubMed
  165. He S, et al. 2021. Front Pharmacol. 12:743837. PubMed
  166. Wang L, et al. 2021. Sci Adv. 7:eabj4796. PubMed
  167. Walker MT, et al. 2021. Front. Allergy. 2:. PubMed
  168. Harb H, et al. 2020. Nat Immunol. 1359:21. PubMed
  169. Niven J, et al. 2019. Cell Rep. 28:21. PubMed
  170. Clemente–Casares X, et al. 2017. Immunity. 47:974. PubMed
  171. Leary N, et al. 2022. J Extracell Vesicles. 11:e12197. PubMed
  172. Xu W, et al. 2021. Immunity. 54(3):526-541.e7. PubMed
  173. Di Pilato M, et al. 2021. Cell. 184(17):4512-4530.e22. PubMed
  174. Chung S, et al. 2020. Am J Physiol Lung Cell Mol Physiol. L921:318. PubMed
  175. Stefan KL, et al. 2020. Cell. 1312:183. PubMed
  176. Porrello A, et al. 2018. Nat Commun. 9:1988. PubMed
  177. Ding L et al. 2018. Cell reports. 25(11):2972-2980 . PubMed
  178. Meng Michelle Xu et al. 2017. Immunity. 47(2):363-373 . PubMed
  179. Yoshida H, et al. 2019. Cell. 176:897. PubMed
  180. Donlan AN, et al. 2021. JCI Insight. 6: . PubMed
  181. Okreglicka K, et al. 2021. J Exp Med. 218:. PubMed
  182. Van Nuffel E, et al. 2020. EMBO Rep. 21:e49237. PubMed
  183. Liu SS, et al. 2021. Immunity. :. PubMed
  184. Xu C, et al. 2021. Cell Reports. 35(11):109235. PubMed
  185. Hildreth AD, et al. 2020. STAR Protoc. 1:100113. PubMed
  186. Rossnagl S, et al. 2016. PLoS Biol. 14: 1002562. PubMed
  187. Wan X, Thomas J, Unanue E 2016. J Exp Med. 213: 967 - 978. PubMed
  188. Yu H, et al. 2015. PLoS One. 10: 0143001. PubMed
  189. Jin J, et al. 2020. Cell Reports. 30(12):4124-4136. PubMed
  190. Schuh E, et al. 2017. J Immunol. 198:3081. PubMed
  191. Tippimanchai DD, et al. 2018. Oncoimmunology. 7:e1438105. PubMed
  192. Stotesbury C, et al. 2020. Aging Cell. 19:e13170. PubMed
  193. Teng F, et al. 2021. Cell Rep. 37:110051. PubMed
  194. Ceglia V, et al. 2021. J Immunol. 207:2060. PubMed
  195. Bahmani B, et al. 2021. Nat Commun. 12:1999. PubMed
  196. Fite BZ, et al. 2021. Sci Rep. 11:927. PubMed
  197. Lee HN, et al. 2022. JCI Insight. 7:. PubMed
  198. Verma M, et al. 2021. J Exp Med. 218:. PubMed
  199. Kim J, et al. 2020. Adv Funct Mater. 30:. PubMed
  200. Lee GR, et al. 2021. JCI Insight. 6:. PubMed
  201. Stack G, et al. 2015. PLoS Pathog. 11:1004641. PubMed
  202. Tran S, et al. 2020. Immunity. 53(3):627-640.e5. PubMed
  203. Goc J, et al. 2021. Cell. :. PubMed
  204. Wunderlich CM, et al. 2018. Nat Commun. 9:1646. PubMed
  205. Albaghdadi AJH, et al. 2019. Sci Rep. 9:6528. PubMed
  206. Ioanna E Galani et al. 2017. Immunity. 46(5):875-890 . PubMed
  207. Crowe J, et al. 2020. PLoS Pathog. 16:e1008391. PubMed
  208. Saleh R, et al. 2018. J Immunol. 201:2042. PubMed
  209. Doo DW, et al. 2020. Ther Adv Med Oncol. 12:1758835920913798. PubMed
  210. Schäfer AL, et al. 2021. Front Immunol. 12:696810. PubMed
  211. Hsu HP, et al. 2021. J Biol Chem. 296:100419. PubMed
  212. Rivera CA, et al. 2022. Immunity. 55:129. PubMed
  213. Dietschmann A, et al. 2020. Eur J Immunol. 50:1044. PubMed
  214. Dai B, et al. 2021. Cell Reports Medicine. 2(8):100381. PubMed
  215. Trivedi S, et al. 2020. Elife. 9:00. PubMed
  216. Hayashi K, et al. 2020. Nat Commun. 4.832638889. PubMed
  217. Fontana C, et al. 2016. J Biol Chem. 291: 7727-7741. PubMed
  218. Uematsu T, et al. 2015. Sci Rep. 5: 17577. PubMed
  219. Thomson CA, et al. 2018. J Immunol. 201:215. PubMed
  220. Chen S, et al. 2018. Nat Commun. 9:5298. PubMed
  221. Zhang Y, et al. 2022. J Immunother Cancer. 10:. PubMed
  222. Lee S, et al. 2021. Autophagy. Online ahead of print. PubMed
  223. Amend A, et al. 2021. Int J Mol Sci. 22:. PubMed
  224. Wirasinha RC, et al. 2021. J Exp Med. 218: . PubMed
RRID
AB_493569 (BioLegend Cat. No. 117317)
AB_493568 (BioLegend Cat. No. 117318)

Antigen Details

Structure
Integrin α-chain, associates with integrin β2 (CD18), 150 kD
Distribution

Dendritic cells, NK cells, intestinal intraepithelial lymphocytes (IEL), some activated T cells

Function
Cellular adhesion
Ligand/Receptor
iC3b, fibrinogen
Cell Type
Dendritic cells, Epithelial cells, NK cells, T cells, Tregs
Biology Area
Cell Adhesion, Cell Biology, Costimulatory Molecules, Immunology, Innate Immunity, Neuroscience, Neuroscience Cell Markers
Molecular Family
Adhesion Molecules, CD Molecules
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen Facts Book Academic Press.
2. Springer TA. 1994. Cell 76:301.
3. Lopez-Rodriguez C, et al. 1996. J. Immunol. 156:3780.

Gene ID
16411 View all products for this Gene ID
UniProt
View information about CD11c on UniProt.org

Related FAQs

There are no FAQs for this product.

Other Formats

View All CD11c Reagents Request Custom Conjugation
Description Clone Applications
APC anti-mouse CD11c N418 FC
Biotin anti-mouse CD11c N418 FC,IHC-F
FITC anti-mouse CD11c N418 FC
PE anti-mouse CD11c N418 FC
Purified anti-mouse CD11c N418 FC,CyTOF®,IP,IHC
Alexa Fluor® 488 anti-mouse CD11c N418 FC
Alexa Fluor® 647 anti-mouse CD11c N418 FC,IHC,ICC,3D IHC
PE/Cyanine5 anti-mouse CD11c N418 FC
PE/Cyanine7 anti-mouse CD11c N418 FC
Brilliant Violet 605™ anti-mouse CD11c N418 FC
Alexa Fluor® 700 anti-mouse CD11c N418 FC
Pacific Blue™ anti-mouse CD11c N418 FC
APC/Cyanine7 anti-mouse CD11c N418 FC
PerCP/Cyanine5.5 anti-mouse CD11c N418 FC
PerCP anti-mouse CD11c N418 FC
Brilliant Violet 421™ anti-mouse CD11c N418 FC,IHC
Brilliant Violet 570™ anti-mouse CD11c N418 FC
Brilliant Violet 785™ anti-mouse CD11c N418 FC
Brilliant Violet 510™ anti-mouse CD11c N418 FC
Brilliant Violet 650™ anti-mouse CD11c N418 FC
Purified anti-mouse CD11c (Maxpar® Ready) N418 FC,CyTOF®
Alexa Fluor® 594 anti-mouse CD11c N418 IHC-F,3D IHC
PE/Dazzle™ 594 anti-mouse CD11c N418 FC
Brilliant Violet 711™ anti-mouse CD11c N418 FC
APC/Fire™ 750 anti-mouse CD11c N418 FC
TotalSeq™-A0106 anti-mouse CD11c N418 PG
Brilliant Violet 750™ anti-mouse CD11c N418 FC
TotalSeq™-B0106 anti-mouse CD11c N418 PG
TotalSeq™-C0106 anti-mouse CD11c N418 PG
KIRAVIA Blue 520™ anti-mouse CD11c N418 FC
Spark Blue™ 550 anti-mouse CD11c N418 FC
Spark NIR™ 685 anti-mouse CD11c N418 FC
Spark UV™ 387 anti-mouse CD11c N418 FC
Spark Red™ 718 anti-mouse CD11c N418 FC
Go To Top Version: 1    Revision Date: 11.30.2012

For research use only. Not for diagnostic use. Not for resale. BioLegend will not be held responsible for patent infringement or other violations that may occur with the use of our products.

 

*These products may be covered by one or more Limited Use Label Licenses (see the BioLegend Catalog or our website, www.biolegend.com/ordering#license). BioLegend products may not be transferred to third parties, resold, modified for resale, or used to manufacture commercial products, reverse engineer functionally similar materials, or to provide a service to third parties without written approval of BioLegend. By use of these products you accept the terms and conditions of all applicable Limited Use Label Licenses. Unless otherwise indicated, these products are for research use only and are not intended for human or animal diagnostic, therapeutic or commercial use.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

  • APC anti-mouse CD11c

  • Biotin anti-mouse CD11c

  • FITC anti-mouse CD11c

  • PE anti-mouse CD11c

  • Purified anti-mouse CD11c

  • Alexa Fluor® 488 anti-mouse CD11c

  • Alexa Fluor® 647 anti-mouse CD11c

  • PE/Cyanine5 anti-mouse CD11c

  • PE/Cyanine7 anti-mouse CD11c

  • Brilliant Violet 605™ anti-mouse CD11c

  • Alexa Fluor® 700 anti-mouse CD11c

  • Pacific Blue™ anti-mouse CD11c

  • APC/Cyanine7 anti-mouse CD11c

  • PerCP/Cyanine5.5 anti-mouse CD11c

  • PerCP anti-mouse CD11c

  • Brilliant Violet 421™ anti-mouse CD11c

  • Brilliant Violet 570™ anti-mouse CD11c

  • Brilliant Violet 785™ anti-mouse CD11c

  • Brilliant Violet 510™ anti-mouse CD11c

  • Brilliant Violet 650™ anti-mouse CD11c

  • Purified anti-mouse CD11c (Maxpar® Ready)

  • Alexa Fluor® 594 anti-mouse CD11c

  • PE/Dazzle™ 594 anti-mouse CD11c

  • Brilliant Violet 711™ anti-mouse CD11c

  • APC/Fire™ 750 anti-mouse CD11c

  • TotalSeq™-A0106 anti-mouse CD11c

  • Brilliant Violet 750™ anti-mouse CD11c

  • TotalSeq™-B0106 anti-mouse CD11c

  • TotalSeq™-C0106 anti-mouse CD11c

  • KIRAVIA Blue 520™ anti-mouse CD11c

  • Spark Blue™ 550 anti-mouse CD11c

  • Spark NIR™ 685 anti-mouse CD11c

  • Spark UV™ 387 anti-mouse CD11c

  • Spark Red™ 718 anti-mouse CD11c
ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account